Personalis(PSNL) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Personalis Reports Second Quarter 2024 Financial Results Strong Revenue Growth of 35% Year-over-Year Driven by 117% Growth from Biopharma Business Raises 2024 Full Year Revenue Guidance FREMONT, Calif. – August 7, 2024 – Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today reported financial results for the second quarter ended June 30, 2024, and provided recent business accomplishments. Recent Business Accomplishments | --- | --- | |--------|------------ ...